期刊文献+

组蛋白去乙酰化酶2表达下调对宫颈癌细胞增殖和细胞周期的影响 被引量:2

Effect of down-regulation of histone deacetylase 2 protein expression on cell proliferation and cell cycle in cervical carcinoma
原文传递
导出
摘要 目的探讨组蛋白去乙酰化酶2(HDAC2)表达下调对宫颈癌细胞增殖和细胞周期的影响,并分析其可能的分子机制。方法将HI)AC2小干扰RNA(siRNA)和对照siRNA转染宫颈癌HeLa细胞,采用细胞增殖与活性检测试剂盒(CCK-8)分析转染前后细胞增殖的变化,利用流式细胞术检测转染前后细胞周期分布的变化,采用Westernblot方法分析与细胞增殖和细胞周期相关蛋白表达的变化。结果HDAC2 siRNA能明显下调宫颈癌细胞中HDAC2蛋白的表达,其表达下调能明显抑制宫颈癌细胞的增殖。HDAC2 siRNA组中HeLa细胞在G0/G1期的细胞比率为63.3%±2.0%,显著高于未处理组(29.3%±1.7%)和对照siRNA组(29.4%±1.7%),F=354.181,P=0.000。Westernblot结果显示,HDAC2表达下调能明显抑制cyclin D1、cyclin E和CDK2蛋白的表达,增加p21蛋白的表达。结论HDAC2表达下调介导的细胞增殖抑制和周期阻滞可能与cyclin D1、cyclin E和CDK2蛋白表达的下调和p21蛋白表达的升高密切相关。 Objective To study the effect of down-regulation of histone deacetylase 2 (HDAC2) expression on cell proliferation and cell cycle in cervical carcinoma cell lines HeLa. Methods HDAC2 siRNA and control siRNA were transfected to HeLa cells. CCK-8 and flow cytometry were used to analyze the changes of cell proliferation and cell cycle, respectively. Western blot was employed to detect the changes of cell proliferation and cell cycle-related proteins. Results HDAC2 siRNA significantly down-regulated the expression of HDAC2 protein in HeLa cells, resulting in marked inhibition of cell proliferation. In addition, the percentage of cells in G0/G1 phase in HDAC2 siRNA group (63.3% ± 2.0% ) was significantly higher than that in untreated group (29.3% ±1.7% ) or control siRNA group (29.4% ±1.7% ) ,F = 354. 181, P = 0. 000. Furthermore, Western blot demonstrated that down-regulation of HDAC2 expression decreased the expression of cyclin D1, cyclin E and CDK2 proteins but increased the expression of p21 protein. Conclusions Down-regulation of HDAC2 expression mediates proliferation inhibition and cell cycle arrest. It is associated with decrease in eyelin D1, cyclin E and CDK2 protein expression and increase in p21 protein expression.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2012年第7期466-469,共4页 Chinese Journal of Pathology
基金 河南省卫生厅科技攻关项目(200802009) 河南省教育厅自然科学研究计划项目(2008A320011)
关键词 宫颈肿瘤 组蛋白去乙酰基酶2 细胞增殖 细胞周期 细胞周期蛋白类 细胞系 肿瘤 Uterine cervical neoplasms Histone deacetylase 2 Cell proliferation Cell cycle Cyclins Cell line, tumor
  • 相关文献

参考文献15

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011,61 (2) : 69-90.
  • 2Pectasides D, Kamposioras K, Papaxoinis G, et al. Chemotherapy for recurrent cervical cancer. Cancer Treat Rev, 2008, 34 (7) : 603-613.
  • 3Yang XJ, Seto E. The Rpd3/Hdal family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol, 2008, 9(3) :206-218.
  • 4Spange S, Wagner T, Heinzel T, et al. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol, 2009, 41 (1) : 185-198.
  • 5Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet, 2009, 10(1) : 32-42.
  • 6Bieliauskas AV, Pflum MK. Isoform-selective histone deacetylase inhibitors. Chem Soc Rev, 2008, 37(7) : 1402-1413.
  • 7Weichert W. HDAC expression and clinical prognosis in human malignancies. Cancer Lett, 2009, 280(2) : 168-176.
  • 8Chang HH, Chiang CP, Hung HC, et al. Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients. Oral Oncol, 2009, 45(7): 610-614.
  • 9袁林林,娄卫华,桑建中,李晟磊,李文才.组蛋白去乙酰化酶2表达下调对喉鳞癌Hep-2细胞凋亡和增殖及迁移的影响[J].中华病理学杂志,2012,41(6):396-399. 被引量:3
  • 10Chang CC, Lin BR, Chen ST, et al. HDAC2 promotes cell migration/invasion abilities through HIF-lα stabilization in human oral squamous cell carcinoma. J Oral Pathol Med, 2011,40(7) : 567 -575.

二级参考文献16

  • 1Sanderson RJ, Ironside JA. Squamous cell carcinomas of the head and neck. BMJ, 2002, 325(7368):822-827.
  • 2Robin PE, Reid A, Powell DJ, et al. The incidence of cancer of the larynx. Clin Otolaryngol Allied Sci, 1991,16 (2) : 198-201.
  • 3Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet, 2009, 10( 1 ) :32-42.
  • 4Mutze K, Langer R, Becker K, et al. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer. Ann Surg Oncol, 2010, 17(12) :3336-3343.
  • 5Langer R, Mutze K, Becker K, et al. Expression of class I histone deacetylases ( HDAC1 and HDAC2 ) in oesophageal adenocarcinomas: an immunohistoehemical study. J Clin Pathol, 2010, 63(11):994-998.
  • 6Adams H, Fritzsche FR, Dirnhofer S, et al. Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin' s lymphoma. Expert Opin Ther Targets, 2010,14 (6) :577-584.
  • 7Fritzsche FR, Weichert W, Roske A, et al. Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer, 2008, 8:381.
  • 8Weichert W, Roske A, Gekeler V, et al. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer, 2008, 98 (3) :604-610.
  • 9Chang HH, Chiang CP, Hung HC, et al. Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients. Oral Oncol, 2009, 45(7):6104514.
  • 10Marshall GM, Gherardi S, Xu N, et al. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene, 2010, 29(44) :5957-5968.

共引文献2

同被引文献10

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部